Biolife Solutions (BLFS) Amortization of Deferred Charges (2011 - 2023)

Biolife Solutions' (BLFS) quarterly Amortization of Deferred Charges came in at $13000.0 in Q1 2023, down 27.78% on a QoQ basis from $18000.0 in Q4 2022.

Biolife Solutions (BLFS) Amortization of Deferred Charges (2011 - 2023) Analysis & Trends

Biolife Solutions (BLFS) has 7 years of Amortization of Deferred Charges data on file, last reported at $13000.0 in Q1 2023.

  • On a quarterly basis, Amortization of Deferred Charges changed N/A year-over-year to $13000.0 in Q1 2023; TTM through Dec 2023 was $13000.0, a 27.78% decrease from a year earlier, with the FY2023 full-year figure at $13000.0, down 27.78% from the prior year.
  • Amortization of Deferred Charges for Q1 2023 stood at $13000.0, down from $18000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for BLFS reached as high as $18000.0 in Q4 2022 and fell as low as $13000.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 126.72 Bn 121.51 Bn 1.96 Bn
2 Becton Dickinson 44.88 Bn 44.07 Bn 2.15 Bn
3 Alcon 33.19 Bn 31.53 Bn 1.53 Bn
4 Medline 32.91 Bn 30.67 Bn 1.84 Bn
5 Resmed 29.46 Bn 27.80 Bn 890.98 Mn
6 West Pharmaceutical Services 23.22 Bn 22.79 Bn 329.20 Mn
7 Solventum 14.06 Bn 13.50 Bn 1.10 Bn
8 Cooper Companies 13.85 Bn 13.71 Bn 735.40 Mn
9 Align Technology 12.13 Bn 11.07 Bn 736.59 Mn
10 Biolife Solutions 1.45 Bn 1.37 Bn 17.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2023 13,000.00
Mar 31, 2023 13,000.00
Dec 31, 2022 18,000.00
Dec 31, 2022 18,000.00
Jun 30, 2016 86,736.00
Jun 30, 2016 86,736.00
Mar 31, 2014 13,022.00
Mar 31, 2014 13,022.00
Dec 31, 2013 14,262.00
Dec 31, 2013 14,262.00
Sep 30, 2013 14,263.00
Sep 30, 2013 14,263.00
Jun 30, 2013 14,107.00
Jun 30, 2013 14,107.00
Mar 31, 2013 13,952.00
Mar 31, 2013 13,952.00
Dec 31, 2012 18,397.00
Dec 31, 2012 18,397.00
Sep 30, 2012 18,397.00
Sep 30, 2012 18,397.00